SELLAS Life Sciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLS and other ETFs, options, and stocks.

About SLS

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. 

CEO
Angelos M. Stergiou
CEOAngelos M. Stergiou
Employees
13
Employees13
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2006
Founded2006
Employees
13
Employees13

SLS Key Statistics

Market cap
1.73B
Market cap1.73B
Price-Earnings ratio
-40.29
Price-Earnings ratio-40.29
Dividend yield
—
Dividend yield—
Average volume
8.79M
Average volume8.79M
High today
$8.69
High today$8.69
Low today
$8.51
Low today$8.51
Open price
$9.63
Open price$9.63
Volume
73.12K
Volume73.12K
52 Week high
$15.88
52 Week high$15.88
52 Week low
$1.39
52 Week low$1.39

Stock Snapshot

The current SELLAS Life Sciences(SLS) stock price is $8.64, with a market capitalization of 1.73B. The stock trades at a price-to-earnings (P/E) ratio of -40.29.

During the trading session on 2026-11-03, SELLAS Life Sciences(SLS) shares reached a daily high of $8.69 and a low of $8.51. At a current price of $8.64, the stock is +1.6% higher than the low and still -0.5% under the high.

Trading activity shows a volume of 73.12K, compared to an average daily volume of 8.79M.

The stock's 52-week range extends from a low of $1.39 to a high of $15.88.

The stock's 52-week range extends from a low of $1.39 to a high of $15.88.

SLS News

Simply Wall St 4d
SELLAS Life Sciences Group (Nasdaq:SLS) - Stock Analysis - Simply Wall St

...

SELLAS Life Sciences Group (Nasdaq:SLS) - Stock Analysis - Simply Wall St
Simply Wall St 5d
SELLAS Shares Enter Final Analysis Phase After Key Leukemia Trial Event

SELLAS Life Sciences Group reported that its pivotal Phase 3 REGAL trial of galinpepimut-S in acute myeloid leukemia has now reached the pre-specified 80th even...

TipRanks 6d
SELLAS Life Sciences Stock Slides 18% as a Phase 3 Study Enters Its Evaluation Period

SELLAS Life Sciences (SLS) stock was hit hard on Wednesday after the company announced a clinical trial update. This update had to do with the late-stage clinic...

More SLS News

Benzinga 6d
SELLAS Life Sciences Stock Stumbles: What's Going On?

SELLAS Life Sciences Group Inc (NASDAQ:SLS) shares are falling Wednesday, pulling back after trading higher earlier in the day, as the company’s Phase 3 leukemi...

SELLAS Life Sciences Stock Stumbles: What's Going On?

People also own

Based on the portfolios of people who own SLS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.